|国家预印本平台
首页|β-arrestins在中枢神经系统疾病中的研究进展

β-arrestins在中枢神经系统疾病中的研究进展

Progress in the Research of β-arrestins in Central Nervous System Diseases

中文摘要英文摘要

β-抑制蛋白(β-arrestins)是一种内吞支架蛋白,介导多种细胞表面受体及非受体蛋白的内吞。然而,β-arrestins除了是传统G蛋白信号的负性调节因子外,还可作为一个多功能接头蛋白调节G蛋白偶联受体的脱敏和转运,启动受体在胞内的多种信号传导,直接或间接地调节基因转录,参与多种疾病的进程。本文对β-arrestins介导的受体内吞以及β-arrestins在中枢神经系统疾病中的研究进展进行综述。

β-arrestins is a type of adaptor protein, which mediated the endocytosis of surface receptors or non-receptor proteins. β-arrestins, which negatively regulating G protein signal, are now well proven to be a multifunctional adaptor protein to desensitize activated G protein-coupled receptors (GPCRs). It can selectively stabilize only a subset of receptor conformations and thus preferentially activating certain signaling mechanisms, participating in a broad range of human physical and disease processes. Here, we provide an overview of the receptor endocytosis by β-arrestins and the study of β-arrestins in central nervous system diseases.

范征、鲁明

基础医学神经病学、精神病学生理学

药理学G蛋白偶联受体β-抑制蛋白阿尔茨海默病帕金森病精神分裂症

pharmacologyGPCRsβ-arrestinsAlzheimer's diseaseParkinson's diseaseschizophrenia

范征,鲁明.β-arrestins在中枢神经系统疾病中的研究进展[EB/OL].(2016-05-20)[2025-08-04].http://www.paper.edu.cn/releasepaper/content/201605-853.点此复制

评论